Research studies in biomedical journals are increasingly scrutinized,
not only for their scientific findings and clinical and public health implications,
but also because of concerns related to conflicts of interest of investigators1 and concerns about misleading reporting of industry-sponsored
research.2 The perception that conflicts of
interest or financial concerns may have potentially detrimental effects on
medical science has prompted medical journals to critically examine and more
vigorously enforce policies for disclosure of potential conflicts and for
reporting of relationships with industry.3